Natco Pharma gains on USFDA nod for Oseltamivir Phosphate - The New Indian Express

Natco Pharma gains on USFDA nod for Oseltamivir Phosphate

Published: 18th March 2014 01:19 PM

Last Updated: 18th March 2014 01:19 PM

Natco Pharma, one of the few Indian companies to venture into new drug discovery research, climbed on Tuesday after it received tentative approval of Oseltamivir Phosphate Capsules USP, 30 mg (base) 45 mg (base) and 75 mg (base) by the United States Foods & Drug administration (USFDA).

Natco is partnered with Alvogen for marketing of Phosphate Capsules.Shares of the company are trading at Rs 829, up Rs 4.9, or 0.59% at the Bombay Stock Exchange (BSE) on Tuesday at 12:44 p.m.The scrip has touched an intra-day high of Rs 850 and low of Rs 824.40. The total volume of shares traded at the BSE is 4,843.In the earlier session, the shares lost 2.03%, or Rs 17.05, at Rs 824.10. Currently, the stock is trading down 5.47% from its 52-week high of Rs 877 and above 112.56% over the 52-week low of Rs 390.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


Read More



follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook